Access the world's trusted COVID-19 data today
Coverage
Solutions for
Products
Newsroom
About
Contact us

Predictions

Our science intelligence looks forward not back. The key is predictive analytics. In partnership with leading universities, Airfinity has pioneered a number of forecasts for the life science industry. All our models are bottom-up and developed by combining data we structure and clean with various advanced statistical tools and machine learning.
Airfinity background image landing page

PREDICTIONS OF PHASE 3 TRIAL READOUTS

Forecasting the timings of large trials is critical for all parts of the life science ecosystem. By combining granular data on trial locations, disease prevalence and end points, we are able to accurately predict read out dates for interim and full analysis for a number of Phase 3 COVID-19 vaccine trials and also infer accurate efficacy estimates from the timings. We are building out these forecasts in a number of areas and enhancing them with more historical data sets.

Weekly science intelligence briefing
Real time analytics platform view

PRODUCTION FORECASTS

Many lives and the world economy depend on the rapid scale up of COVID-19 vaccine production. Through mapping manufacturing sites and supply chain dynamics, analysing historic production rates and capacity, Airfinity generates accurate predictions on vaccine production and realistic supply forecasts.

Weekly science intelligence briefing
Real time analytics platform view

SUPPLY AND DEMAND MODELS

Combining production forecasts with virus variants of concern, vaccine hesitancy, efficacy and effectiveness assumptions as well as variants of concern prevalence, Airfinity models supply and demand dynamics for vaccines and therapeutics across 140 countries.

Weekly science intelligence briefing
Real time analytics platform view

APPROVAL PROBABILITY

Airfinity’s compound centric science analytics and impact metrics, including real time meta-analysis and KOL sentiment, serve as predictors for approval likelihood and guideline inclusion of a given drug candidate.

Weekly science intelligence briefing
Real time analytics platform view

INFECTIONS AND PANDEMIC PROBABILITY

Our data science team has developed a machine learning model that accurately predicts 1-2 week infection rates at regional and country specific levels. We are working on combining this model with the world leading COVID-19 infection forecasts developed by the epidemiology team Imperial College London to improve our ability to predict longer term infections and enhance our pandemic risk alerts.

Weekly science intelligence briefing
Real time analytics platform view

PRICING AND MARKET SHARE

Airfinity uses efficacy and safety data from trials in real-time to calculate the health economics of a new innovation. Combining this with pricing and deal data, we build evidence-based bottom-up market share and pricing forecasts.

Weekly science intelligence briefing
Real time analytics platform view

SOCIAL MEDIA SENTIMENT CLASSIFIER

Social media has become a key source of scientific information but eliminating the noise is difficult. We have built a sentiment and semantic classifier to analyse large scale social media data and derive results on overall sentiment on a particular drug.

Weekly science intelligence briefing
Real time analytics platform view

Sign up to receive a biweekly sample of our insights

Airfinity will never share your data with any third parties. By completing this form you are agreeing to being contacted for marketing communications. Our Privacy Policy can be found here.

Free for 3 months for verified organisations only.

To schedule a demo today, contact us. To receive our media briefings, email press@airfinity.com.

Airfinity background image landing page

Coverage

Copyright © Airfinity Limited 2021.
Privacy Policy